Alkermes PLC (NAS:ALKS)
$ 24.34 -0.04 (-0.16%) Market Cap: 4.12 Bil Enterprise Value: 3.75 Bil PE Ratio: 9.62 PB Ratio: 3.28 GF Score: 66/100

Alkermes Plc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 02:40PM GMT
Release Date Price: $16.62
Brandon Richard Folkes
Cantor Fitzgerald & Co., Research Division - Analyst

Good morning, everyone, and welcome to the 2020 Cantor Fitzgerald Virtual Health Care Conference this year. Thank you very much for joining us.

I am Brandon Folkes, one of the biopharma analysts here at Cantor. And next up on the schedule, we have a fireside chat with Alkermes. And joining us from Alkermes is CEO, Richard Pops; and Iain Brown, SVP of Finance.

Just a word to those who are joining us, we will likely run short of time for Q&A on this fireside chat. So if you do have any questions, please e-mail them directly to me. I'll get them across to the company, and the company will get back to you.

Questions & Answers

Brandon Richard Folkes
Cantor Fitzgerald & Co., Research Division - Analyst

Maybe just bringing in, Rich, thank you very much for joining us. Can you just give us a brief overview of where Alkermes is currently? I think most people are familiar with the company. But just in terms of how has COVID continued to impact the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot